Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ ProDots Human IGF-I Recombinant Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

$49.00 - $289.00

Specifications

Gene Alias IBP1, IGF1, IGF-1, IGF1A, IGFI, IGF-I, IGF-IA, IGF-IB, insulin-like growth factor 1, insulin-like growth factor 1 (somatomedin C), insulin-like growth factor I, insulin-like growth factor IA, insulin-like growth factor IB, Mechano growth factor, MGF, Somatomedin A, Somatomedin C, Somatomedin-C
Source E. coli
Conjugate Unlabeled
Recombinant Yes
Gene ID (Entrez) 3479
View More Specs

Products 3
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
PRD29101 View Documents R&D Systems™
PRD29101
5μg Each for $49.00
Add to cart
 
PRD29110 View Documents R&D Systems™
PRD29110
50μg Each for $149.00
Add to cart
 
PRD29150 View Documents R&D Systems™
PRD29150
250μg Each for $289.00
Add to cart
 
Description

Description

The ProDots Recombinant Human IGF-I/IGF-1 Protein is derived from E. coli. The ProDots Recombinant Human IGF-I/IGF-1 Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

IBP1, IGF1, IGF-1, IGF1A, IGFI, IGF-I, IGF-IA, IGF-IB, insulin-like growth factor 1, insulin-like growth factor 1 (somatomedin C), insulin-like growth factor I, insulin-like growth factor IA, insulin-like growth factor IB, Mechano growth factor, MGF, Somatomedin A, Somatomedin C, Somatomedin-C
Unlabeled
3479
Human
IGF1
<0.10 EU per 1μg of the protein by the LAL method.
Bioactivity
E. coli
Yes
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Observed M.W.: 7kDa, reducing conditions, Theoretical M.W.: 7.6kDa
Measured in a serum-free cell proliferation assay using MCF-7 human breast cancer cells. Karey, K.P. et al. (1988) Cancer Research 48:4083. The ED50 for this effect is typically 0.3-1.5ng/mL.
P05019
E. coli-derived Gly49 - Ala118
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit